Search clinical trials for: Breast Expanders

Total 16834 results

Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

Breast Cancer | Breast Neoplasms | Breast Adenocarcinoma

United States
University in Zielona Góra
ConvaTec Inc.

Unknown

Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction

Breast Cancer | Breast Reconstruction

Poland
Lesley Wong

Completed

Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction

Breast Cancer

United States
Emory University

Withdrawn

Antibiotics and Tissue Expanders in Breast Reconstruction

Complications; Breast Prosthesis, Infection or Inflammation
Integra LifeSciences Corporation

Withdrawn

SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy

Breast Cancer
NYU Langone Health

Withdrawn

Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders

Breast Cancer

United States
Yaron Har-Shai

Unknown

The Effect of Breast Reconstruction Surgery Using Tissue Expanders on Respiratory Functions

Breast Reconstruction | Respiratory Function

Israel
Mayo Clinic
University of California, San Francisco; Ethicon, Inc.

Completed

Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction

Breast Cancer | Nonmalignant Breast Conditions

United States
University of Colorado, Denver

Completed

A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders

Breast Cancer

United States
Yunnan Cancer Hospital
Affiliated Cancer Hospital of Shantou University Medical College

Not yet recruiting

Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Image and Virtual Staining

Breast Cancer | Lymph Node Metastasis | Digital Pathology | Virtual Staining
Kahramanmaras Sutcu Imam University
Inonu University

Not yet recruiting

Breastfeeding Counseling Training on Breast Milk Perception and Baby Feeding Attitudes (EFFBCTBP)

MİDWİFERY STUDENT
University Hospital Southampton NHS Foundation...
Tellspec Ltd

Not yet recruiting

Preemie Milk Analyser Validation Study

Breast Milk Expression | Pre-Term | Nutrition Disorder, Infant

United Kingdom
University of Kansas Medical Center

Not yet recruiting

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

Obesity | Breast Cancer Risk

United States
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT

Lung Cancer | Inoperable Disease

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer

Breast Cancer
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Metastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Andy Hill Cancer Research Endowment (CARE)...

Not yet recruiting

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials (GUIDE)

Breast Carcinoma | Digestive System Carcinoma | Genitourinary System Carcinoma

United States
Wuhan Union Hospital, China

Not yet recruiting

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma | To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer | Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to...
Fudan University

Recruiting

Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Breast Neoplasm Female | Financial Toxicity | Financial Navigation

China
University Hospital Schleswig-Holstein
University of Southern Denmark; Medical School Hamburg

Not yet recruiting

Dermatitis During Adjuvant Irradiation for BREAst Cancer: (DAI-BREAC)

Breast Cancer Female

Germany, Denmark
George Washington University

Not yet recruiting

Diet, Hepcidin, and Chemotherapy RDI

Gynecologic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Breast Cancer Female | Primary Peritoneal Carcinoma

United States
Rita Assi

Not yet recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

B-cell Lymphoma | Refractory Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin Lymphoma | Relapsed Hodgkin Lymphoma

United States
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Antibody | Liver Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

Breast Cancer | HER2-positive Breast Cancer | Circulating Tumor DNA | Neoadjuvant

China
UMC Utrecht
World Cancer Research Fund International

Not yet recruiting

Cancer Of the BReast Asanas (COBRA) Study (COBRA)

Breast Cancer
Teva Branded Pharmaceutical Products R&D, Inc.

Not yet recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors
Ain Shams University

Recruiting

Modified Pectoral Nerve Block Vs Thoracic Erector Spinae Plane Block for Analgesia for Aesthetic Breast Surgeries

Postoperative Pain

Egypt
The University of Texas Health Science Center,...
National Center for Advancing Translational Sciences (NCATS)

Not yet recruiting

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Breast Cancer Survivorship

United States
European Institute of Oncology

Recruiting

Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients

Breast Cancer | Estrogen Receptor Positive Tumor

Italy
European Institute of Oncology

Not yet recruiting

Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer (SURGYPET)

Breast Cancer | Breast-conserving Surgery

Italy
Bristol-Myers Squibb

Not yet recruiting

A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants

Healthy Volunteers
Wuhan Union Hospital, China

Not yet recruiting

Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging (COMBO-I)

Breast Cancer

China
The Netherlands Cancer Institute
Maarten van de Weijden Foundation; AVL Foundation

Not yet recruiting

OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes (OPTImaL)

Breast Cancer Stage I | Triple Negative Breast Cancer (TNBC)

Netherlands
Henan Cancer Hospital

Not yet recruiting

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

Metastatic Breast Cancer in the Brain
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Not yet recruiting

A Study of DM001 in Patients With Advanced Solid Tumors

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Solid Carcinoma
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC

Not yet recruiting

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

Lymphoma | Primary Central Nervous System Lymphoma

United States
Maria Sklodowska-Curie National Research Institute...

Recruiting

Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer (BREAST-BOOSTER)

Breast Cancer

Poland
GlaxoSmithKline
iTeos Therapeutics

Recruiting

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Lung Cancer, Non-Small Cell

Argentina, Belgium, Brazil, Canada, Finland, Germany, Italy, Japan, Mexico, Panama, Spain, Taiwan, Turkey, Poland, Netherlands, Korea, Republic of, France, Greece, Bulgaria, Croatia, Czechia, Estonia, Hong Kong, Hungary, India, Philippines, Portuga... and more
Zunyi Medical College

Recruiting

A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy

HER-2 Positive Advanced Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Not yet recruiting

To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer

Breast Cancer | HR+/HER2- Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer

Triple-negative Breast Cancer

China
University of California, San Francisco
Merck Sharp & Dohme LLC; Astellas Pharma Inc

Not yet recruiting

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Bladder Cancer | Muscle-Invasive Bladder Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8

United States
Merck Sharp & Dohme LLC

Not yet recruiting

Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Adenocarcinoma | Gastroesophageal Junction
BriaCell Therapeutics Corporation

Recruiting

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Breast Cancer | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the Breast | Tumors, Breast

United States
Fudan University

Not yet recruiting

Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer

Advanced Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer

China
Karolinska Institutet

Recruiting

To Live Better After Breast Cancer Treatment

Breast Cancer Survivorship

Sweden
Anaveon AG
Merck Sharp & Dohme LLC

Recruiting

A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)

Advanced Solid Tumor

Switzerland
King's College London

Not yet recruiting

Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases (PDO)

Breast Neoplasms
European Institute of Oncology

Recruiting

Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer

Cancer

Italy
Xin-Wu Cui
Hubei Cancer Hospital; First Affiliated Hospital of Kunming Medical University and other collaborators

Recruiting

Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study

Breast Cancer Female

China

Search clinical trials for: Breast Expanders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations